Metolazone
Pricing Report NDC 65580-644-71

Latest NADAC: $1.11569 per EA · Effective Dec 18, 2019 · Est. package price $111.57 (100 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

The latest wholesale acquisition cost for Metolazone (NDC 65580-644-71) is $1.11569 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Dec 18, 2019.

As a provided by Upstate Pharma, Llc, this medication is distributed in a 100 TABLET in 1 BOTTLE, PLASTIC configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$1.11569
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Dec 18, 2019
Billable Units
100 EA
Estimated Package Price
$111.57
Data Status
As of Jan 01, 2020
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
65580-644-71
Description
100 TABLET in 1 BOTTLE, PLASTIC
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.55324 to $1.51990 per EA. Over this 6 years period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.5532 - $1.5199
Market Volatility
174.73% Variance
Latest Trend
11.85%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Dec 18, 2019 $1.11569 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 20, 2019 $1.26564 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 23, 2019 $1.09874 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 18, 2019 $1.11407 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 21, 2019 $1.17734 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 17, 2019 $1.15913 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 19, 2019 $1.30933 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 22, 2019 $1.24830 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 17, 2019 $1.27889 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 20, 2019 $1.16775 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 20, 2019 $1.12433 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 23, 2019 $1.11937 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026